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Strategies of Adjuvant Therapy 
Edited by John M Kirkwood, Martin Dunitz Publishers, 2000,
240 pp, £65.00. 1 85317 3177 
Biological therapies are an accepted part of anti-cancer treatment
despite displaying only limited efficacy in early trials, which were
largely in the setting of metastatic disease. The recent publication
of studies describing the effect of adjuvant interferon treatment for
melanoma highlights the potential of these agents at an earlier
stage of the illness. In addition, our increasing understanding of
the mechanisms of action of such agents permits the identification
of new targets for treatment and better elucidation of the patient
population likely to benefit from intervention. 
Strategies in Adjuvant Therapy describes the potential for
development of adjuvant biological therapies in a number of
tumour types via a series of monographs. These are authoritative
updates of ongoing research efforts in their particular fields but not
all fulfil the brief described in the title and preface to the book.
This is particularly true of the chapter on lymphoma: although
giving an exhaustive account of novel therapeutics and their intra-
cellular effects scant attention is paid to their use in the adjuvant
setting, although trials in advanced disease are described. The
discussion of renal cell cancer is similarly guilty of a concentration
on therapy for advanced, metastatic disease with only a token
attempt to relate this to adjuvant therapy. Furthermore, major
ongoing studies are not covered. 
The division of the book in site-specific chapters means that
common themes in the development of adjuvant biological thera-
pies are not emphasized. A summary of the issues concerning
therapeutic target identification, patient selection/staging and
treatment evaluation might have been a useful addition to the text.
The chapters on melanoma stand out in that they explicitly address
these problems in developing new treatments, but it is unfortunate
that these strategic considerations are not given greater promin-
ence. Molecular staging has its own chapter, which describes
concisely the state of the art and problems associated with the
accuracy of current techniques, but does not compare these with
conventional staging protocols or with developing techniques such
as sentinel node sampling. 
Despite these minor reservations this remains a comprehen-
sive account of an area in which radical changes can soon be
expected. There are useful summaries of work in common
tumours such as lung, breast, colorectal and prostate, as well as
less prevalent cancers. For the general oncologist this provides
an accessible summary of current trends in the development of
adjuvant therapies and a useful update on biological therapy for
other stages of disease. There is also sufficient detail for the site
specialist and an extensive list of references to facilitate further
reading. 
Mark Middleton 
Christie Hospital
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Atlas of Breast Cancer, Second Edition 
Edited by Daniel F. Hayes, Mosby, London, 2000 
I did not have the good fortune of seeing the first edition of this
Atlas, but the second is impressive. This is an Atlas which is
clearly different from others in the field in being truly comprehen-
sive. Apart from being an excellent practical guide to the manage-
ment of breast cancer it has a strong underpinning of the biological
and statistical foundations on which our current understanding of
the disease is based. As stated in the preface by the editor, Dr
Daniel Hayes, the idea of this Atlas germinated during discussions
and teaching sessions at the breast unit of Dana-Farber Cancer
Institute, and the reader will immediately recognize this connec-
tion from the choice of topics and the practical manner in which
these are presented. The book comprises of 13 chapters and has
approximately 100 pages with numerous beautifully coloured
illustrations and tables which are easy to comprehend. In addition
to Dr Hayes, there are 6 contributors but the book has been care-
fully edited with a clear flow of ideas. 
The Atlas starts with an introductory chapter on natural history
of breast cancer and is followed by one on risk factors, epidemio-
logy, and development of breast cancer. The biological aspects of
initiation, promotion and metastasis are beautifully depicted with
illustrations. The diagram illustrating linkage analysis which led to
the discovery of the familial breast cancer genes is particularly
attractive and explicit. The general aspects of oncogenes and
tumour suppressor genes are also presented in pictorial format.
The third chapter is devoted to normal anatomy and development
of the breast followed by one on breast cancer prevention. Here,
the age-related risk profiles of different groups of women is shown
in graphic format which the reader will find informative. The
current status of breast cancer prevention has been rightfully
presented with caution. The chapter on imaging has an American
slant with screening mammography being recommended starting
age 40. 
The chapters on breast cancer surgery and processing of breast
biopsies will be particularly useful for those training to become
breast cancer surgeons. The techniques of breast conserving surgery
and breast reconstruction are well illustrated. The methodologies
for the detection of oestrogen receptor and c-erbB-2 oncogene
over-expression/amplification are pictorially depicted for the
benefit of those unfamiliar with these techniques. Benign disor-
ders and pathology of breast cancer are explained with the use of
beautiful and representative photomicrographs. The chapter on
radiotherapy is excellent with clear diagrammatic representation
of practical issues such as margin status after lumpectomy and
factors that predict risk of local failure. The management of posi-
tive margins is very successfully presented in a picture format. In
many places in the clinical chapters relevant figures from the
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